Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Regenerative Medicine

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1352255

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1352255

Stromal Vascular Fraction

PUBLISHED:
PAGES: 214 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 14850

Add to Cart

Description

Table of Contents

What`s New?

» Special discussions on the global economic climate and market sentiment

» Coverage on global competitiveness and key competitor percentage market shares

» Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial

» Online interactive peer-to-peer collaborative bespoke updates

» Access to our digital archives and MarketGlass™ research platform

» Complimentary updates for one year

» Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

Economic Outlook

The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US$6 trillion economy by 2030, surpassing Japan and Germany.

The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Stromal Vascular Fraction Market to Reach $116.9 Million by 2030

The global market for Stromal Vascular Fraction estimated at US$82.2 Million in the year 2022, is projected to reach a revised size of US$116.9 Million by 2030, growing at a CAGR of 4.5% over the period 2022-2030. Isolation Products, one of the segments analyzed in the report, is projected to record 4.3% CAGR and reach US$91.4 Million by the end of the analysis period. Growth in the Aspiration Products segment is estimated at 5.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $29.5 Million, While China is Forecast to Grow at 5.8% CAGR

The Stromal Vascular Fraction market in the U.S. is estimated at US$29.5 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$9.7 Million by the year 2030 trailing a CAGR of 5.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 4.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Select Competitors (Total 25 Featured) -

  • GE HealthCare PLC
  • Kyocera Corporation
  • Stempeutics Research Pvt., Ltd.
  • Genesis Biosystems, Inc.
  • IntelliCell BioSciences, Inc.
  • human med AG
  • InGeneron, Inc.
  • iXCells Biotechnologies
  • Jointechlabs, Inc.
  • Froceth
  • GID BIO
  • Obatala Sciences
Show more
Product Code: MCP15044

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Stromal Vascular Fraction - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Stem Cells, Application Areas, and the Different Types: A Prelude
    • Applications of Stem Cells
    • Types of Stem Cells
    • Stromal Vascular Fraction: An Introduction
    • Production Method for SVF
    • SVF Cell Procedure
    • SVF Composition, Content, and Source
    • SVF: Mechanism of Action
    • SVF: Clinical Applications
    • Safety and Efficiency of SVF
    • Clinical Trials and Regulations Related to SVF
    • Limitations and Scope
    • Impact of Covid-19 and a Looming Global Recession
    • COVID-19 Impact on Stromal Vascular Fraction Market
  • GLOBAL MARKET OVERVIEW
    • Extensive Therapeutic Scope Set to Stimulate Growth of Global Stromal Vascular Fraction Market
    • Soft Tissue Segment Leads the Market
    • North America Dominates the Global Market, Asia-Pacific to Witness Fastest Growth
    • Lucrative Opportunities & Restraints
    • Market Restraints
    • Salient Drivers Offering Growth Impetus to Stromal Vascular Fraction Market
    • Extensive Application Scope
    • Rising Focus on Non-Enzymatic Isolation Techniques
    • Strong Research Focus on Optimization of Tissue Recovery
    • Consistent Efforts to Develop Better Cell Therapies
    • Competition
    • Players Bet on Product Innovation to Push Footprint in Stromal Vascular Fraction Market
    • Recent Market Activity
    • SVF Isolation Products Continue to Make Gains
  • 2. FOCUS ON SELECT PLAYERS
  • PIPELINE ANALYSIS
  • 3. MARKET TRENDS & DRIVERS
    • Regenerative Medicine: A Promising Application of Stromal Vascular Fraction
    • Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025
    • Global Stem Cell & Regenerative Medicine Market by Product (in %) for the Year 2019
    • Global Regenerative Medicines Market by Category: Breakdown (in %) for Biomaterials, Stem Cell Therapies and Tissue Engineering for 2019
    • Increased Prevalence of Musculoskeletal Disorders & Knee Osteoarthritis Steers Market Expansion
    • Use of SVF in Osteoarthritis Treatment
    • Surging Demand for Aesthetic & Reconstructive Therapies Enhances Market Prospects
    • Total Number of Surgical Procedures Performed across the Globe by Plastic Surgeons (2018)
    • Total Number of Surgical Procedures across the Globe by Region of the Body: 2018
    • Increasing Awareness about Stem Cell Therapy Augurs Well
    • Innovative Methods Become Relevant in Optimizing Tissue Recovery
    • Stromal Vascular Formation Holds Significance for Chronic Diseases
    • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • Stromal Vascular Fraction in Diabetic Care
    • Rising Diabetes Prevalence Presents Opportunity for iPSCs Market: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
    • Low Temperature Settings Optimize Vitality of Adipose Tissue-derived SVFs
    • SVF Offers Helpful Microenvironment to Regulate ASC Activity under Specific Clinical Conditions
    • Swift Influx of Stem Cell Therapies Requires Alternate Regulatory Pathway Covering Autologous SVF
    • The Counterview
    • Contrast with Regulatory Framework Covering HCT/Ps
    • Aging Demographics Add to the Global Burden of Chronic Diseases, Presenting Opportunities for Stromal Vascular Fracture
    • Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
    • High Incidence of Neurological Disorders: A Key Market Driver
    • Annual Incidence of Adult-Onset Neurologic Disorders in the US
    • Diagnosed Prevalence Cases of Parkinson's Disease Across Select Countries
    • Increase in Healthcare Spending Stirs Demand for Stromal Vascular Formation
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Expansion of Private Hospitals in Rural Areas
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Isolation Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Isolation Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Aspiration Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Aspiration Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Transfer Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Transfer Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Soft Tissue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Soft Tissue by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Cosmetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Cosmetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Orthopedic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 18: World 8-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Stem Cell Banks/Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World 8-Year Perspective for Stem Cell Banks/Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 22: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 23: World Stromal Vascular Fraction Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 25: World 8-Year Perspective for Stromal Vascular Fraction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA 8-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2023 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 29: USA 8-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2023 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 31: USA 8-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2023 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada 8-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2023 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Canada 8-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2023 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Canada 8-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2023 & 2030
  • JAPAN
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan 8-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2023 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 41: Japan 8-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2023 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 43: Japan 8-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2023 & 2030
  • CHINA
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China 8-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2023 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 47: China 8-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2023 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 49: China 8-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2023 & 2030
  • EUROPE
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe 8-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2023 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Europe 8-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2023 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 55: Europe 8-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2023 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe 8-Year Perspective for Stromal Vascular Fraction by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
  • FRANCE
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 59: France 8-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2023 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 61: France 8-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2023 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: France 8-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2023 & 2030
  • GERMANY
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Germany 8-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2023 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Germany 8-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2023 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Germany 8-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2023 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Italy 8-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2023 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 73: Italy 8-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2023 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Italy 8-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2023 & 2030
  • UNITED KINGDOM
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 77: UK 8-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2023 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 79: UK 8-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2023 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: UK 8-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 8-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2023 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 8-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2023 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 8-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Stromal Vascular Fraction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 8-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2023 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 8-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2023 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 8-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Product Type - Isolation Products, Aspiration Products and Transfer Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Rest of World 8-Year Perspective for Stromal Vascular Fraction by Product Type - Percentage Breakdown of Value Sales for Isolation Products, Aspiration Products and Transfer Products for the Years 2023 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Stromal Vascular Fraction by Application - Soft Tissue, Cosmetic, Orthopedic and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 97: Rest of World 8-Year Perspective for Stromal Vascular Fraction by Application - Percentage Breakdown of Value Sales for Soft Tissue, Cosmetic, Orthopedic and Other Applications for the Years 2023 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Stromal Vascular Fraction by End-Use - Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Rest of World 8-Year Perspective for Stromal Vascular Fraction by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories and Other End-Uses for the Years 2023 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!